No Detail Found!

Mid-trimester termination of pregnancy-comparison of sublingual with vaginal misoprostol.

Author(s)
Lubna Javed Department of Obstetrics and Gynaecology, Jinnah Hospital, Lahore and Department of Anatomy, Fatima Jinnah Medical College, Lahore, Pakistan
Mariam Malik Department of Obstetrics and Gynaecology, Jinnah Hospital, Lahore and Department of Anatomy, Fatima Jinnah Medical College, Lahore, Pakistan
Naheed Jamal Department of Obstetrics and Gynaecology, Jinnah Hospital, Lahore and Department of Anatomy, Fatima Jinnah Medical College, Lahore, Pakistan
Shahida Sheikh Department of Obstetrics and Gynaecology, Jinnah Hospital, Lahore and Department of Anatomy, Fatima Jinnah Medical College, Lahore, Pakistan
Fozia Farzana Department of Obstetrics and Gynaecology, Jinnah Hospital, Lahore and Department of Anatomy, Fatima Jinnah Medical College, Lahore, Pakistan
Abstract
This paper compares the efficacy, side effects and patients satisfaction of sublingual with vaginal misoprostol.for mid-trimester termination of pregnancy. The study was performed in the department of Obstetrics and Gynaecology, Jinnah Hospital, Lahore. One hundred patients presenting for termination of pregnancy between 13-24 wks of gestation were selected. They were divided into two groups, group 1 was managed with sublingual and group II with vaginal misoprostol. The dose of misoprostol was 200 µg repeated at intervals of 6 hours up to a maximum of four doses. The primary outcome measure was induction expulsion interval and secondary outcomes were maternal complications, and women`s acceptance of the termination procedure. Successful termination was achieved in 96% patients in group 1 and 94% in group II. The patients in the two groups were comparable regarding their parity, gestational age and indications for termination. As regards the dosage, 76% in each group required a dose of 400 - 600 µg (P value 0. 000). Induction expulsion interval was 0.003). Pyrexia > 38°C was found in 8% and 6% in each group respectively while 8% in group 1 and 4% in group II had nausea and vomiting. So, sublingual misoprostol is as effective as vaginal misoprostol but with more nausea and vomiting, which can be managed easily. As a conclusion misoprostol can play a very important role in the practice of obstetrics and gynaecology in resource poor countries where cost of other prostaglandins is prohibitively high and temperature maintenance is a problem. In proper dosage the risk of complications is low and most of the patients achieve completion of expulsion in less than 12 hrs by both routes.
Publication Details
Page(s) 56-59
DOI DOI not available
Published Journal: Biomedica, Volume: 20, Issue: 1, Year: 2004

Request the full text from PASTIC

0

Citations

0

Downloads

49

Views